Sai Life Sciences Partners with Dassault Systèmes to Advance Drug Discovery 

Share via:

Sai Life Sciences, one of India’s leading contract research, development, and manufacturing organisations, aims to accelerate drug discovery by partnering with Dassault Systemes, a leader in product lifecycle management (PLM) solutions and others.

In a recent announcement, Dassault Systèmes revealed that Sai Life Sciences has chosen their technology to enhance data quality, and foster collaboration within the organisation’s Research and Process Development laboratories. This move is expected to reshape the landscape of pharmaceutical research and development.

Sai Life Sciences is harnessing the power of Dassault Systemes’ industry solution experience, named “ONE Lab,” which operates on the innovative 3DEXPERIENCE platform. This solution leverages BIOVIA applications for seamless data accessibility and analysis.

The organisation seeks to create an integrated digital platform that seamlessly connects its R&D and chemistry, manufacturing, and controls (CMC) laboratories. This initiative aims to address some of the most pressing challenges faced by the pharmaceutical research sector, particularly those related to project implementation.

Sai Life Sciences aims to reduce errors, save time, promote sustainability practices, and establish a unified, reliable source of information that fosters collaboration among multiple stakeholders, spanning research, development, and commercial manufacturing.

Dr. Damodharen, chief quality officer at Sai Life Sciences, echoed this sentiment, stating, “The integration of Dassault Systemes’ ‘ONE Lab’ empowers us to drive productivity, enhance data quality, and fortify data security, revolutionising our approach to research across the entire spectrum from early-stage development to commercial manufacturing.”

The implementation of “ONE Lab” has played a role in empowering Sai Life Sciences to construct an all-encompassing digital platform for its R&D and CMC laboratories. 

Overcoming common project implementation challenges, particularly in the realm of change management, has been a remarkable achievement in this endeavour. “ONE Lab” offers various benefits to the industry, including laboratory optimization and knowledge utilisation for accelerated time-to-market.  

The post Sai Life Sciences Partners with Dassault Systèmes to Advance Drug Discovery  appeared first on Analytics India Magazine.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Sai Life Sciences Partners with Dassault Systèmes to Advance Drug Discovery 

Sai Life Sciences, one of India’s leading contract research, development, and manufacturing organisations, aims to accelerate drug discovery by partnering with Dassault Systemes, a leader in product lifecycle management (PLM) solutions and others.

In a recent announcement, Dassault Systèmes revealed that Sai Life Sciences has chosen their technology to enhance data quality, and foster collaboration within the organisation’s Research and Process Development laboratories. This move is expected to reshape the landscape of pharmaceutical research and development.

Sai Life Sciences is harnessing the power of Dassault Systemes’ industry solution experience, named “ONE Lab,” which operates on the innovative 3DEXPERIENCE platform. This solution leverages BIOVIA applications for seamless data accessibility and analysis.

The organisation seeks to create an integrated digital platform that seamlessly connects its R&D and chemistry, manufacturing, and controls (CMC) laboratories. This initiative aims to address some of the most pressing challenges faced by the pharmaceutical research sector, particularly those related to project implementation.

Sai Life Sciences aims to reduce errors, save time, promote sustainability practices, and establish a unified, reliable source of information that fosters collaboration among multiple stakeholders, spanning research, development, and commercial manufacturing.

Dr. Damodharen, chief quality officer at Sai Life Sciences, echoed this sentiment, stating, “The integration of Dassault Systemes’ ‘ONE Lab’ empowers us to drive productivity, enhance data quality, and fortify data security, revolutionising our approach to research across the entire spectrum from early-stage development to commercial manufacturing.”

The implementation of “ONE Lab” has played a role in empowering Sai Life Sciences to construct an all-encompassing digital platform for its R&D and CMC laboratories. 

Overcoming common project implementation challenges, particularly in the realm of change management, has been a remarkable achievement in this endeavour. “ONE Lab” offers various benefits to the industry, including laboratory optimization and knowledge utilisation for accelerated time-to-market.  

The post Sai Life Sciences Partners with Dassault Systèmes to Advance Drug Discovery  appeared first on Analytics India Magazine.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Copilot Money review: The best budgeting app gets better...

I’ve written before about Copilot’s crucial role in...

OpenAI CEO Sam Altman says lack of compute capacity...

In a Reddit AMA, OpenAI CEO Sam Altman...

Kalshi secures tens of millions in loans from VCs,...

Investors are rushing to throw millions at a...

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!